Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication
2011

Alcohol's Impact on HIV/AIDS Mortality

publication Evidence: moderate

Author Information

Author(s): Gerrit Gmel, Kevin D. Shield, Jürgen Rehm

Primary Institution: Centre for Addiction and Mental Health (CAMH)

Hypothesis

Can we derive alcohol-attributable fractions for HIV/AIDS mortality based on its effect on adherence to antiretroviral medication?

Conclusion

The method developed is feasible and provides estimates of the impact of alcohol use on HIV/AIDS mortality.

Supporting Evidence

  • Alcohol consumption is linked to nonadherence to antiretroviral treatment.
  • Nonadherence to treatment increases mortality in HIV-infected individuals.
  • The method estimates AAFs for HIV/AIDS mortality based on adherence rates.

Takeaway

Drinking alcohol can make it harder for people with HIV to stick to their medicine, which can lead to more deaths from the disease.

Methodology

The study combined data from various sources to estimate alcohol-attributable fractions (AAFs) for HIV/AIDS mortality across five African regions.

Potential Biases

Potential biases may arise from the reliance on published data and the categorization of alcohol consumption.

Limitations

The method does not account for the effects of alcohol on HIV/AIDS outcomes in the absence of treatment.

Participant Demographics

The study focused on populations in five Global Burden of Disease regions in Africa, with variations in alcohol consumption and HIV/AIDS prevalence.

Statistical Information

Confidence Interval

95% CI: 0.12, 0.56

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1478-7954-9-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication